Keros Therapeutics, Inc. (KROS)
10.98
-1.00
(-8.38%)
USD |
NASDAQ |
May 14, 16:00
10.98
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics EPS Diluted (Quarterly) : -0.8626 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 2.878 |
| PTC Therapeutics, Inc. | -0.034 |
| Insmed, Inc. | -0.7591 |
| United Therapeutics Corp. | 5.824 |
| Opus Genetics, Inc. | -0.7542 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.46M |
| Revenue (Quarterly) | 0.385M |
| Total Expenses (Quarterly) | 23.85M |
| Enterprise Value | -34.12M |
| Gross Profit Margin (Quarterly) | -3.90% |
| Profit Margin (Quarterly) | -6.09K% |
| Earnings Yield | 16.58% |
| Operating Earnings Yield | 16.48% |
| Normalized Earnings Yield | 16.60 |